The invention relates to a method for identifying a therapeutic having analogous activity to a thiazolidinedione by contacting a cell containing a PPAR&ggr; receptor with a candidate therapeutic; and determining the level of a selected gene expression; to indicate that the candidate therapeutic is a therapeutic for treating a disease associated with a PPAR&ggr; receptor. The invention also relates to a composition comprising a plurality of selected genes or gene fragments, or a plurality of proteins or proteins fragments selected from proteins encoded by the selected genes thereof. The invention further relates to a method for determining whether a subject is responsive to treatment with a therapeutic having analogous activity to a thiazolidinedione.
本发明涉及一种识别具有类似
噻唑烷二酮活性的治疗方法,通过将含有
PPAR&ggr;受体的细胞与候选治疗药物接触,并确定所选
基因表达
水平,以表明候选治疗药物是治疗与
PPAR&ggr;受体相关疾病的治疗药物。本发明还涉及一种组合物,包括多个所选
基因或
基因片段,或多个从所选
基因编码的蛋白质或蛋白质片段中选择的蛋白质。本发明还涉及一种确定受试者是否对具有类似
噻唑烷二酮活性的治疗药物治疗反应的方法。